Clinical Trial Update: A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial evaluating the efficacy and safety of meloxicam oral suspension in juvenile idiopathic arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Juvenile Rheumatoid | Phase 3 | Status: COMPLETED